Paul M Beringer

17PUBLICATIONS
22CO-AUTHORS
Medical mycologyGene and molecular therapyCarbon capture engineering (excl. sequestration)Psychosocial aspects of childbirth and perinatal mental healthPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jun 13, 2026
Effect of concomitant rifampin and clarithromycin on elexacaftor-tezacaftor-ivacaftor using a physiologically based pharmacokinetic (PBPK) modeling approach.

|Mar 15, 2026
Current State of Clinical Care of People With Cystic Fibrosis.

Cameron J McKinzie, Charissa W Kam, Paul M Beringer

|Nov 12, 2025
Evaluation of Elexacaftor/Tezacaftor/Ivacaftor-Mediated Drug-Induced Liver Injury Using a Liver-On-Chip Model.

Alan Shi, Palak Agarwal, Zhang-Xu Liu

|Sep 23, 2025
Quantitative Systems Toxicology Predicts Ivacaftor-Induced Oxidative Stress Contributes to CFTR Modulator Hepatotoxicity.

Alan Shi, Cole Cornwell, Kyunghee Yang

|May 05, 2025
Predicting Maternal and Fetal Exposures of Elexacaftor-Tezacaftor-Ivacaftor during Pregnancy through Physiologically Based Pharmacokinetic Models.

Eunjin Hong, Mary F Hebert, Emily Fay

|Mar 27, 2025
Evaluation of Complex Drug Interactions Between Elexacaftor-Tezacaftor-Ivacaftor and Statins Using Physiologically Based Pharmacokinetic Modeling.

Eunjin Hong, Peter S Chung, Adupa P Rao

Pageof 3

Frequent Collaborators

7 joint publications

Eunjin Hong

3 joint publications

Alan Shi

2 joint publications

Madeline Sanders

2 joint publications

Peter S Chung